Celldex Therapeutics (CLDX) Amortization - Intangibles (2010 - 2018)
Celldex Therapeutics (CLDX) recorded quarterly Amortization - Intangibles of $224000.0 in Q1 2018, little changed quarter-over-quarter from $224000.0 in Q4 2017, and little changed on a YoY basis from $224000.0 in Q1 2017.
Celldex Therapeutics (CLDX) Amortization - Intangibles (2010 - 2018) Analysis & Trends
Celldex Therapeutics' Amortization - Intangibles history runs 9 years deep, the most recent figure standing at $224000.0 for Q1 2018.
- In Q1 2018, Amortization - Intangibles changed 0.0% year-over-year to $224000.0; the TTM figure through Dec 2018 stood at $224000.0 (down 75.0% YoY), while the FY2018 annual figure was $224000.0, down 75.0% from the prior year.
- Amortization - Intangibles was $224000.0 for Q1 2018 at Celldex Therapeutics, roughly flat from $224000.0 in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $254000.0 in Q2 2014 to a low of $224000.0 in Q1 2017.
- Historically, Amortization - Intangibles has averaged $243882.4 across 5 years, with a median of $253000.0 in 2014.
- The sharpest annual moves came in 2014 and 2017: Amortization - Intangibles changed 0.0% in 2014, then slipped 11.81% in 2017.
- A 5-year view of Amortization - Intangibles shows it stood at $253000.0 in 2014, then changed by 0.0% to $253000.0 in 2015, then decreased by 6.32% to $237000.0 in 2016, then declined by 5.49% to $224000.0 in 2017, then changed by 0.0% to $224000.0 in 2018.
- The last three Amortization - Intangibles figures came in at $224000.0 (Q1 2018), $224000.0 (Q4 2017), and $224000.0 (Q3 2017), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Celldex Therapeutics | 2.16 Bn | 2.16 Bn | -1.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 224,000.00 |
| Dec 31, 2017 | 224,000.00 |
| Sep 30, 2017 | 224,000.00 |
| Jun 30, 2017 | 224,000.00 |
| Mar 31, 2017 | 224,000.00 |
| Dec 31, 2016 | 237,000.00 |
| Sep 30, 2016 | 254,000.00 |
| Jun 30, 2016 | 254,000.00 |
| Mar 31, 2016 | 253,000.00 |
| Dec 31, 2015 | 253,000.00 |
| Sep 30, 2015 | 254,000.00 |
| Jun 30, 2015 | 254,000.00 |
| Mar 31, 2015 | 253,000.00 |
| Dec 31, 2014 | 253,000.00 |
| Sep 30, 2014 | 254,000.00 |
| Jun 30, 2014 | 254,000.00 |
| Mar 31, 2014 | 253,000.00 |
| Dec 31, 2013 | 253,000.00 |
| Sep 30, 2013 | 254,000.00 |
| Jun 30, 2013 | 254,000.00 |